The Latest
-
J&J’s recent medtech buys help to prop up devices unit
Johnson & Johnson’s medtech acquisitions over the past year have fueled growth for its cardiovascular group, offsetting challenges in businesses like orthopedics and surgery.
-
FTC increases premerger reporting requirements over provider objections
Companies will be required to disclose more information about minority investors and past M&A activity. Provider groups said the new requirements would be burdensome for hospitals.
-
Hologic to buy Gynesonics for $350M to acquire fibroid system
Gynesonics’ transcervical system uses ultrasound guidance and radiofrequency energy to ablate fibroids without the need for an incision.
-
Medtronic to evaluate Affera in ventricular tachycardia
The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in patients with ventricular tachycardia, an abnormal heart rhythm.
-
The Medtech Conference
4 trends to watch at Advamed’s The Medtech Conference
As medtech companies, experts and regulators gather in Toronto, FDA leadership changes and the upcoming U.S. presidential election loom over the industry.
-
J&J, Abbott and Intuitive kick off latest medtech earnings season
From pulsed field ablation to diabetes tech and surgical robots, the updates will provide an early look at how key medtech markets performed last quarter.
-
Digital health deal count declines in Q3, but check sizes stabilize: Rock Health
Startups notched 110 deals in the third quarter, compared with 133 in the second quarter. But average deal size held steady, suggesting investors are making “fewer, more focused bets,” according to the consultancy firm.
-
Fresenius Medical Care increasing IV, dialysis solutions production to alleviate shortages
B. Braun and Fresenius Medical Care said they will make more crucial products as the U.S. faces shortages following Hurricane Helene’s damage to a Baxter manufacturing facility.
-
Abbott enrolls pivotal PFA study 4 months ahead of schedule
The company reported the enrollment milestone alongside news that it received clearance to sell its Advisor HD Grid X Mapping Catheter and started a trial of its Tactiflex Duo Ablation Catheter.
-
Solventum names Egeland as chief medical officer
Ryan Egeland, former CEO and co-founder of Crossfire Medical, rounds out the leadership team for the 3M spinoff.
-
Baxter ups IV fluid allocations amid supply shortages
As hospitals around the U.S. report IV fluid shortages, Baxter has increased supply allocations for direct customers and distributors. It plans on returning to 90% to 100% allocation of certain supplies by the end of 2024.
-
CMR Surgical CEO Bose steps down
Massimiliano Colella, who joined the surgical robotics firm in late 2023, was named interim CEO.
-
Shiratronics raises $66M for trial of neuromodulation migraine device
The funding will support the trial, premarket approval application and initial commercial launch of a system that could interrupt or change the transmission of pain signals to the brain.
-
Deep Dive
The number of AI medical devices has spiked in the past decade
The FDA has authorized nearly 1,000 medical devices with artificial intelligence features as companies including GE Healthcare and Siemens Healthineers build out their AI efforts.
-
Procept secures FDA approval to study surgical robot in prostate cancer
The trial will compare the therapy to radical prostatectomy and could unlock a market that analysts value at $500 million.
-
AHA asks Biden administration for relief amid IV fluid shortage from Hurricane Helene
Hospitals have been contending with shortages of the life-saving supplies after Hurricane Helene damaged Baxter's manufacturing plant in North Carolina, according to the American Hospital Association.
-
Baxter says no structural damage at North Carolina site hit by Hurricane Helene
The facility also has access to water and power. Baxter expects to share production plans over the next two weeks.
-
Mercury Medical recalls emergency resuscitators
Healthcare professionals use the devices to provide newborns and infants with emergency breathing support.